Circulating metabolite profile in young adulthood identifies long-term diabetes susceptibility: the Coronary Artery Risk Development in Young Adults (CARDIA) study

[1]  Alexander R. Pico,et al.  Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults , 2020, Circulation.

[2]  Alexander R. Pico,et al.  Metabolic Architecture of Acute Exercise Response in Middle-Aged Adults in the Community. , 2020, Circulation.

[3]  H. Suleria,et al.  Altered Metabolome of Lipids and Amino Acids Species: A Source of Early Signature Biomarkers of T2DM , 2020, Journal of clinical medicine.

[4]  Ling Li,et al.  N1-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation , 2020, Journal of diabetes research.

[5]  Xiang Chen,et al.  The mechanisms of lysophosphatidylcholine in the development of diseases. , 2020, Life sciences.

[6]  M. Alizadeh,et al.  The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial , 2020, Diabetology & Metabolic Syndrome.

[7]  M. McCarthy,et al.  Glutamine Links Obesity to Inflammation in Human White Adipose Tissue. , 2019, Cell metabolism.

[8]  C. Gelfi,et al.  Sphingolipids in Obesity and Correlated Co-Morbidities: The Contribution of Gender, Age and Environment , 2019, International journal of molecular sciences.

[9]  P. Almgren,et al.  Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality , 2019, Journal of the American Heart Association.

[10]  S. Nayak,et al.  Purine metabolites can indicate diabetes progression , 2019, Archives of physiology and biochemistry.

[11]  A. Błachnio-Zabielska,et al.  The Role of Ceramides in Insulin Resistance , 2019, Front. Endocrinol..

[12]  Qingchang Li,et al.  Trigonelline reduced diabetic nephropathy and insulin resistance in type 2 diabetic rats through peroxisome proliferator-activated receptor-γ. , 2019, Experimental and therapeutic medicine.

[13]  R. Noordam,et al.  The proposed systemic thermogenic metabolites succinate and 12,13-diHOME are inversely associated with adiposity and related metabolic traits: evidence from a large human cross-sectional study , 2019, Diabetologia.

[14]  C. Bouchard,et al.  Association of Dimethylguanidino Valeric Acid With Partial Resistance to Metabolic Health Benefits of Regular Exercise. , 2019, JAMA cardiology.

[15]  L. Liang,et al.  High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[16]  Zhaoping Li,et al.  Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance , 2019, Diabetes.

[17]  H. Fan,et al.  Gut microbe–generated metabolite trimethylamine N‐oxide and the risk of diabetes: A systematic review and dose‐response meta‐analysis , 2019, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[18]  M. Laakso,et al.  Nine Amino Acids Are Associated With Decreased Insulin Secretion and Elevated Glucose Levels in a 7.4-Year Follow-up Study of 5,181 Finnish Men , 2019, Diabetes.

[19]  M. Hedayati,et al.  Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial , 2019, BMC Research Notes.

[20]  Elizabeth T. Cirulli,et al.  Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk , 2019, Cell metabolism.

[21]  F. Tinahones,et al.  Type 2 Diabetes Is Associated with a Different Pattern of Serum Polyamines: A Case–Control Study from the PREDIMED-Plus Trial , 2019, Journal of clinical medicine.

[22]  T. Lehtimäki,et al.  Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts , 2019, bioRxiv.

[23]  Fude Fang,et al.  Spermidine ameliorates non-alcoholic fatty liver disease through regulating lipid metabolism via AMPK. , 2018, Biochemical and biophysical research communications.

[24]  O. Melander,et al.  Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes , 2018, The Journal of clinical endocrinology and metabolism.

[25]  L. Ferrucci,et al.  Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults , 2018, The Journal of clinical endocrinology and metabolism.

[26]  E. Richter.  Faculty of 1000 evaluation for 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. , 2018 .

[27]  Y. Tseng,et al.  12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. , 2018, Cell metabolism.

[28]  Thomas J. Wang,et al.  Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose , 2018, Diabetologia.

[29]  D. Siscovick,et al.  Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study , 2018, Diabetes.

[30]  A. Kostic,et al.  Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites. , 2018, Cell reports.

[31]  Martha Franco,et al.  Glycine Increases Insulin Sensitivity and Glutathione Biosynthesis and Protects against Oxidative Stress in a Model of Sucrose-Induced Insulin Resistance , 2018, Oxidative medicine and cellular longevity.

[32]  J. Manson,et al.  Metabolic Predictors of Incident Coronary Heart Disease in Women , 2018, Circulation.

[33]  L. Groop,et al.  N1-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism , 2018, Scientific Reports.

[34]  C. Serrano-Nascimento,et al.  Beneficial effects of thyroid hormone on adipose inflammation and insulin sensitivity of obese Wistar rats , 2018, Physiological reports.

[35]  H. Jang,et al.  Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle , 2018, Scientific Reports.

[36]  Valerio Chiurchiù,et al.  Bioactive Lipids and Chronic Inflammation: Managing the Fire Within , 2018, Front. Immunol..

[37]  D. Goff,et al.  Intermuscular Adipose Tissue and Subclinical Coronary Artery Calcification in Midlife: The CARDIA Study (Coronary Artery Risk Development in Young Adults) , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[38]  R. Vasan,et al.  Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes , 2017, The Journal of clinical investigation.

[39]  T. Spector,et al.  Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome , 2017, Scientific Reports.

[40]  Zuo Zhang,et al.  Trigonelline Inhibits Inflammation and Protects β Cells to Prevent Fetal Growth Restriction during Pregnancy in a Mouse Model of Diabetes , 2017, Pharmacology.

[41]  M. Blüher,et al.  The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue , 2017, Nature Medicine.

[42]  T. Spector,et al.  Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling , 2017, International Journal of Obesity.

[43]  C. Lewis,et al.  Transitions in Metabolic Risk and Long‐Term Cardiovascular Health: Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2016, Journal of the American Heart Association.

[44]  O. Franco,et al.  Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study , 2016, BMC Medicine.

[45]  Jing Zhang,et al.  Asparagine improves intestinal integrity, inhibits TLR4 and NOD signaling, and differently regulates p38 and ERK1/2 signaling in weanling piglets after LPS challenge , 2016, Innate immunity.

[46]  P. Calder,et al.  Impairment of lysophospholipid metabolism in obesity: altered plasma profile and desensitization to the modulatory properties of n-3 polyunsaturated fatty acids in a randomized controlled trial. , 2016, The American journal of clinical nutrition.

[47]  C. Serrano-Nascimento,et al.  Thyroid hormone reduces inflammatory cytokines improving glycaemia control in alloxan‐induced diabetic wistar rats , 2016, Acta physiologica.

[48]  T. Reinehr,et al.  Tyrosine Is Associated with Insulin Resistance in Longitudinal Metabolomic Profiling of Obese Children , 2015, Journal of diabetes research.

[49]  John M Asara,et al.  Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization , 2015, Nature Medicine.

[50]  Michael Jerosch-Herold,et al.  Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. , 2014, JACC. Cardiovascular imaging.

[51]  M. Fischer,et al.  Alterations of Plasma Lysophosphatidylcholine Species in Obesity and Weight Loss , 2014, PloS one.

[52]  Albert Koulman,et al.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.

[53]  Thomas J. Wang,et al.  Metabolite Traits and Genetic Risk Provide Complementary Information for the Prediction of Future Type 2 Diabetes , 2014, Diabetes Care.

[54]  James G Terry,et al.  Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study. , 2014, Atherosclerosis.

[55]  Inês Barroso,et al.  Impact of Type 2 Diabetes Susceptibility Variants on Quantitative Glycemic Traits Reveals Mechanistic Heterogeneity , 2014, Diabetes.

[56]  E. Gibney,et al.  Relationship between the lipidome, inflammatory markers and insulin resistance. , 2014, Molecular bioSystems.

[57]  J. DiNicolantonio,et al.  The cardiometabolic benefits of glycine: Is glycine an ‘antidote’ to dietary fructose? , 2014, Open Heart.

[58]  Y. Niu,et al.  Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial , 2013, Diabetologia.

[59]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[60]  A. Moser,et al.  Functions of plasmalogen lipids in health and disease. , 2012, Biochimica et biophysica acta.

[61]  Daling Zhu,et al.  Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension , 2012, The Journal of Physiological Sciences.

[62]  Y. Niu,et al.  Histidine and arginine are associated with inflammation and oxidative stress in obese women , 2011, British Journal of Nutrition.

[63]  Kun Wook Chung,et al.  Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance[S] , 2011, Journal of Lipid Research.

[64]  H. Yokomizo,et al.  Biliverdin protects against the deterioration of glucose tolerance in db/db mice , 2011, Diabetologia.

[65]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[66]  Takashi Ito,et al.  The potential usefulness of taurine on diabetes mellitus and its complications , 2011, Amino Acids.

[67]  Sun Young Park,et al.  Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy , 2011, Diabetes.

[68]  Michelle M Wiest,et al.  The plasma lipidomic signature of nonalcoholic steatohepatitis , 2009, Hepatology.

[69]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[70]  J. Cooke,et al.  Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[71]  W. Buczko,et al.  1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway , 2007, British journal of pharmacology.

[72]  R. Koopman,et al.  Changes in Age at Diagnosis of Type 2 Diabetes Mellitus in the United States, 1988 to 2000 , 2005, The Annals of Family Medicine.

[73]  P. Weber,et al.  Phytanic acid, a natural peroxisome proliferator‐activated receptor agonist, regulates glucose metabolism in rat primary hepatocytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  M. Lorenzo,et al.  Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. , 2001, Diabetes.

[75]  B. Egan,et al.  Nonesterified fatty acids in blood pressure control and cardiovascular complications , 2001, Current hypertension reports.

[76]  R. Thurman,et al.  Production of superoxide and TNF-alpha from alveolar macrophages is blunted by glycine. , 1999, The American journal of physiology.

[77]  C. Lewis,et al.  Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. , 1999, The American journal of clinical nutrition.

[78]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[79]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.